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Abstract To isolate the apoptosis-linked genes involved in the
cell death of thymocytes induced by glucocorticoids, we
developed a functional cloning assay. Murine CD4+CD8+
thymic cell line 2-257-20 cells were transfected with cDNA
expression libraries obtained from a dexamethasone-resistant
cell line. The transfected cells were selected in the presence of
dexamethasone, and the plasmids which episomally expanded
were then extracted from the surviving cells. One of the rescued
cDNAs was found to be an antisense cDNA fragment identical to
the mouse mitochondrial ATPase 6 gene. In the stable
transfectants with the ATPase 6 antisense gene, the induction
of apoptosis by dexamethasone was significantly delayed.
Furthermore, the ATP synthesis in these transfectants was also
reduced to some extent. ATPase 6 is a subunit of FoF1 ATPase
and our results support that ATP synthesis from the mitochon-
dria is necessary for the induction of apoptosis induced by
glucocorticoids. ß 2000 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Apoptosis, or programmed cell death, is a naturally occur-
ring process of cell suicide that plays a critical role in the
development and maintenance of metazoans by eliminating
either super£uous or unwanted cells [1,2]. More than 50 years
ago, the thymus gland was ¢rst observed to undergo hyper-
trophy in association with adrenocortical insu⁄ciency and
atrophy in association with adrenocortical excess [3]. We
now know that this phenomenon is due to the gain or loss
of apoptosis in the thymocytes induced by glucocorticoids
(GCs) [4]. Subsequently, it was clari¢ed that GC-induced ap-
optosis is mediated through GC receptor and requires the
translocation of the receptor from the cytoplasm into the
nucleus. In the nucleus, the GC receptor functions as a
transcription factor, either enhancing or repressing the ex-
pression of a selected repertoire of genes [5]. Furthermore,
GC can modify the cellular functions by cross-talking with
other transcription factors, notably AP-1 [6] and NF-UB [7].
Although a previous paper has reported GC-induced apopto-
sis to be primarily mediated by interference with other tran-
scription factors essential for cell survival [8], Reichardt et al.
presented compelling evidence that GC-induced apoptosis in
murine thymocytes requires DNA binding of the GC receptor
by introducing a point mutation into the GC receptor gene
[9].
After the transcription of several genes, the signals from
GC receptor are expected to be conveyed to the mitochondria.
Thereafter, cytochrome c will be released and interact directly
with Apaf-1. This complex activates caspase 9, which in turn
activates caspase 3 or 7, followed by the cleavage of various
death substrates [10]. The ¢nal steps of apoptosis induced by
GCs have thus been rather well de¢ned, but all the steps,
especially those between the binding of GC receptor to
DNA and the mitochondria, still remain to be elucidated.
In addition to the regulation of the cell number of thymo-
cytes in the thymus, GC mainly exerts its lethal e¡ect on the
immature CD4CD8 thymocytes located in the cortex, and
CD4CD83 or CD43CD8 cells in the medulla are relatively
resistant [11]. This di¡erential e¡ect is similar to that observed
in apoptosis induced via T cell receptor. Interestingly,
although both stimuli are known to be lethal by themselves,
GC- and T cell receptor-mediated signals prevent each other’s
induction of apoptosis in CD4CD8 thymocytes [12]. It is
speculated that the balance of these two stimuli may in part
thus regulate the process of thymocyte selection [13]. A clar-
i¢cation of all the steps of apoptosis induced by GCs will
hopefully shed further light on this speculation.
We have designed a method to select genes involved in ap-
optosis in thymocytes by using a murine CD3CD4CD8
thymocyte cell line (2-257-20). This selection system is based
on the assumption that a transfected cDNA library, con-
structed in the mammalian expression vector pPyori-SRK-
BX, should protect some recipient cells from death [14^16].
Such an inhibition may depend on either the inactivation of
apoptotic genes by antisense RNA or dominant negative mu-
tants, or on the expression of proteins with anti-apoptotic
activity. Using this system, we isolated several genes, desig-
nated dexamethasone-induced apoptosis related genes (DI-
ARGs), and one of them was found to act as antisense of
the ATPase 6 gene. The signi¢cance of ATP synthesis in the
development of apoptosis by GCs was discussed.
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2. Materials and methods
2.1. Plasmids
pPyori-SRK-BX was constructed as follows. The BglII site of
pPyOICAT [17], which was kindly supplied by Dr. Y. Ito (Kyoto
University, Japan), was changed to the HindIII site. Then the Hin-
dIII^EcoRI fragment containing the polyoma virus (Py) replication
origin core sequence was isolated. This fragment was inserted between
the HindIII and EcoRI sites of pBluescript II SK (Stratagene, La
Jolla, CA, USA). Next, the HindIII^SalI fragment of pSRK-BX3
(Dr. Takebe, Japanese National Institute of Health), containing the
SRK promoter sequence constructed from a pSRK296 expression vec-
tor, was inserted between the HindIII and EcoRI sites of the vector.
The cDNA library was inserted into pPyori-SRK-BX. pPyLT-BSD
was constructed as follows. The SmaI^EcoRI fragment of pMAM2-
BSD (Funakoshi, Tokyo, Japan) containing the blasticidin S hydro-
chloride drug-resistant (BSD) sequence was isolated. The fragment
was blunt ended using T4 polymerase (Toyobo, Osaka, Japan), ligated
and then digested with BglII (pMAM2-BSDvEcoRI-vSmaI). The
BglII^BamHI fragment of pRSV-LT containing polyoma virus large
T antigen was isolated and inserted into the BglII site of pMAM2-
BSDvEcoRI-vSmaI.
2.2. Sequencing
The samples were prepared by performing £uorescence-based di-
deoxy sequencing reactions using the BigDye1 DNA Sequencing kit
(ABI, Columbia, MD, USA). The samples were analyzed by the Ap-
plied Bio-systems model 310 DNA Sequencing System (PE Applied
Biosystems, Foster City, CA, USA).
2.3. Cell lines
CD3CD4CD8 thymic cell line 2-257-20 was established from a
cell suspension culture of CD4CD8 thymic lymphoma RVC [18]
which was induced with a radiation leukemia virus in new born
BALB/c mice. The cells were sensitive to the apoptosis induced by
dexamethasone (Dex), cyclic AMP and anti-CD3 antibody. Dex-resis-
tant cell line 7-15 was selected from ethyl methanesulfonate-treated
2-257-20 cells. Tag2 cells were established by transfecting 2-257-20
with pPyLT-BSD plasmid and express polyoma virus large T antigen.
All of the murine thymocyte cell lines were maintained in a culture
medium RPMI 1640 supplemented with 2 mM glutamine, 50 Wg/ml
streptomycin, 50 U/ml penicillin, 5U1035 M 2-mercaptoethanol, 10
mM HEPES and 10% fetal calf serum (FCS; Hyclone: lot AGD 6389,
Logan, UT, USA).
2.4. Obtaining stable transfectants with the antisense ATPase 6 gene
Logarithmically growing 2-257-20 cells were harvested, washed and
resuspended in phosphate-bu¡ered saline (PBS). Next, 25 Wg of ex-
pression plasmid pMAM2-BSD containing an antisense cDNA frag-
ment was added to the cell suspension, and thereafter, electroporation
was carried out at 300 mV and 960 WF with a Gene Pulsar (Bio-Rad,
Hercules, CA, USA). The cells were allowed to recover in 10 ml of
liquid culture medium for 24 h, and then the cells were distributed
into each well of a 24-well plate at 2U105 cells/ml/well in the presence
of blasticidin S hydrochloride (Funakoshi, Tokyo, Japan) at a ¢nal
active concentration of 10 Wg/ml. Drug-resistant colonies were visible
10^14 days later, removed from the plate, and grown in liquid culture
medium. Mock transfectant M10 and stable transfectants with ATP-
ase 6 antisense MMK4, MMK6, MMK8, MMK10, MMK12 and
MMK27 were also used in this study.
2.5. Cell viability and cyto£uorometric determination of
apoptosis-associated alterations
The cells were suspended at 2U105/ml and 1 ml of cell suspension
was seeded into each well of a 24-well plate. Cell death was induced
by treatment with 1 WM Dex (Merck, Rahway, NJ, USA) and the
viability was determined with trypan blue. The frequency of sub-
diploid cells was determined by staining Nonidet P40-permeabilized
cells with propidium iodide (PI) (Sigma, St. Louis, MO, USA), and
then the phosphatidylserine (PS) exposure on the outer membrane was
assessed after treatment with FITC^annexin V (Boehringer Mann-
heim, Germany) (15 min at room temperature) and PI. To evaluate
mitochondrial membrane potential (v8m) [19], cells were incubated
with 3,3P-dihexyloxacarbocyanine iodide (DiOC6(3)) (Molecular
Probes, Eugene, OR, USA) at 20 nM for 15 min at 37‡C in 5%
CO2. Cyto£uorometry was performed on a FACSCalibur analyzer
(Becton Dickinson, Mountain View, CA, USA).
2.6. Ribonuclease protection assay
To determine the expression of ATPase 6 antisense mRNA in trans-
fected cell lines (MMK6, MMK12), the ribonuclease protection assay
was performed using a RPA III1 kit (Ambion, Austin, TX, USA).
Transfected cell lines were either untreated or stimulated with 1 WM
Dex for 4 h. The cDNA fragment of ATPase 6 was cloned into
pBluescript II SK (Stratagene, La Jolla, CA, USA) to synthesize an
antisense cRNA probe labeled with [K-32P]CTP (Amersham, UK) us-
ing T7 RNA polymerase (Gibco BRL, Rockville, MD, USA). In
brief, 7.0U105 cpm of probe was hybridized to 20 Wg of total RNA
at 42‡C for 12 h. Unhybridized RNA molecules were then digested
with 112.5 units of RNase A and 4500 units of RNase T1. The pro-
tected molecules were resolved by electrophoresis and then were visu-
alized by autoradiography.
2.7. ATP assays
The intracellular ATP levels of thymocyte cell lines were determined
by the luciferin-luciferase method [20] after the cells were incubated in
RPMI 1640 (10% FCS) medium for 24 h. Next, 3U106 cells were
rapidly collected and washed with PBS, then the cells were resus-
pended in 500 Wl of ice-cold 3% perchloric acid. The samples were
centrifuged at 13 000 rpm for 10 min. A 400-Wl aliquot of the super-
natant was neutralized with KOH and HCl. The volume was adjusted
to 500 Wl with H2O, and the samples were centrifuged. 10 Wl of sample
was injected into 200 Wl of an ATP Determination kit standard reac-
tion solution containing luciferin and luciferase (Molecular Probes,
Eugene, OR, USA). The resulting light emission was then measured
in a luminometer (Lumat LB 9501, Berthold, Germany). The inhibi-
tion of ATP synthesis by oligomycin was evaluated by incubating
M10 and MMK12 cells in the presence of 10 WM oligomycin in a
glucose-free RPMI 1640 medium supplemented with 2 mM glutamine,
1 mM sodium pyruvate, 5U1035 M 2-mercaptoethanol and 10% dia-
lyzed FCS.
3. Results
3.1. Cloning DIARG-1, an antisense cDNA fragment identical
to the mouse mitochondrial ATPase 6 gene
A thymus cell line, Tag2, expressing polyoma LT antigen
(pPyLT-BSD) was transfected with the cDNA library con-
structed from the Dex-resistant mutant subclone, 7-15, in
pPyori-SRK-BX vector, and selected with both blasticidin S
(10 Wg/ml) and Dex (1 WM). Transfection was carried out with
the DEAE dextran method modi¢ed by Takai et al. [21], and
the transfection e⁄ciency was determined to be around 1%
using the lacZ expression vector (pSRK-lacZ). After 21 days,
the cells that survived in the presence of Dex were collected,
and then the episomal DNA was extracted. Several rescued
pPyori-SRK plasmids were pooled (50 clones), re-transfected
further and selected with both blasticidin S and Dex. After a
Fig. 1. Expression of ATPase 6 antisense mRNA in transfected cell
lines. Transfectants of antisense ATPase 6 cDNA (MMK6 and
MMK12) and mock transfectant (M10) were stimulated with or
without 1 WM Dex for 4 h. Total RNA was extracted and the ex-
pression of antisense mRNA was detected with the ribonuclease
protection assay as described in Section 2.
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third screening, we isolated several cDNA clones, designated
DIARGs. The size of the cDNA inserts ranged between 300
and 4000 bp. Next, the cDNA inserts were sequenced. One of
them, DIARG-1, was found to be an antisense cDNA frag-
ment identical to the mouse mitochondrial ATPase 6 gene.
This cDNA was 840 bp long, and the open reading frame
started from the initiation codon at nucleotide positions
139^142 and ended at the termination codon TAA at posi-
tions 818^820. The homology among several species (mouse,
rat, hamster, bovine and human) ranged between 71 and 85%
(data not shown).
3.2. Expression of ATPase 6 antisense mRNA in transfected
cell lines
To detect the expression of antisense mRNA of the ATPase
6 gene, MMK6 and MMK12 cells were incubated either with
or without 1 WM Dex for 4 h. Total RNA was extracted and
an RNA protection assay was performed. As shown in Fig. 1,
the expression of mRNA was clearly detected in MMK6 and
MMK12 cells without the stimulation of Dex, and in MMK12
cells the level of expression increased to some extent when
stimulated with Dex. In contrast, no such expression was de-
tected in either 2-257-20 cells or mock transfectant M10 cells.
3.3. Inhibition of Dex-induced apoptosis in transfectants with
antisense ATPase 6 cDNA
Cell death was induced by treatment with 1 WM Dex in
various transfectants. At 0, 24, and 48 h the cells were har-
vested and the cell viability was determined (Fig. 2). All of the
six stable transfectants with antisense ATPase 6 showed a
reduced susceptibility to the killing e¡ect of Dex, especially
when the viability was assessed at 24 h.
The induction of apoptosis causes various alterations in the
cells, and it was investigated cyto£uorometrically whether or
not the expression of antisense ATPase 6 gene could also
interfere with these alterations. One of the typical events in
apoptosis is the fragmentation of nuclear DNA and this phe-
nomenon can be detected as the appearance of subdiploid
cells when the cell cycle was analyzed with PI. As shown in
Fig. 3a, the increase in the frequency of subdiploid cells at
24 h was greatly reduced in MMK12 cells, although no large
di¡erence was observed between the M10 and MMK12 cells
at 48 h.
Furthermore, in the advanced stage of apoptosis, PS is ex-
posed to the outer plasma membrane, and this event is detect-
able as the binding of annexin V. The results in Fig. 3b again
demonstrated that the alteration of the cell membrane at 24 h
Fig. 2. Inhibition of cell death in transfectants with antisense ATP-
ase 6 gene. The cells were resuspended in RPMI 1640 (10% FCS)
medium and subjected to the following treatments at 37‡C: 1 WM
Dex for 0, 24 and 48 h. The percentage of surviving cell was calcu-
lated from the percentage of the trypan blue-negative populations.
Fig. 3. Thymocyte cell lines expressing antisense transcripts to ATP-
ase 6 are protected from apoptosis-associated alterations. a: A cell
cycle analysis of thymocyte cell lines expressing antisense transcripts
to ATPase 6. Exponentially growing M10 or MMK12 cells were
washed twice and resuspended at a concentration of 2U105 cells/ml.
After 0, 24 or 48 h, cells were stimulated with 1 WM Dex. At the in-
dicated times, cells were collected, and the cell cycle distribution
was assessed by PI staining and analyzed by FACSCalibur. The ¢g-
ures indicate the frequency of subdiploid cells. b: The kinetics of
Dex-induced PS externalization on thymocyte cell lines expressing
antisense transcripts to ATPase 6. Single cell suspensions of M10
and MMK12 cells were washed, resuspended at 5U105/ml in com-
plete medium and plated in a ¢nal volume of 1 ml in 24-well £at-
bottom tissue culture plates. The following cell death stimuli were
administered: 1 WM Dex for 24 or 48 h. Treated and untreated cell
lines were cultured at 37‡C in 5% CO2, followed by harvesting,
staining with FITC^annexin V and PI for 15 min at room tempera-
ture. After washing twice, the cells were analyzed using a FACSCa-
libur using Cell Quest software. From each sample, 1U105 events
were collected. c: The disruption of mitochondrial transmembrane
potential was evaluated by staining M10 and MMK12 cells with Di-
OC6(3) at 20 nM for 15 min, 37‡C in 5% CO2 24 h after stimula-
tion with 1 WM Dex. Cyto£uorometric analysis was performed on a
FACSCalibur analyzer.
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was also inhibited in MMK12 cells, although the di¡erence at
48 h was marginal between M10 and MMK12 cells.
During the various steps before cell death, a disruption of
v8m was also observed, and it is interesting to ask whether
this disruption precedes or follows the inhibitory e¡ects due to
the expression of the antisense gene of mitochondrial ATPase
6. The potential-sensitive dye DiOC6(3) was used to evaluate
the change in the mitochondrial membrane potential. As
shown in Fig. 3c, the loss of v8m was less in MMK12 cells
than that observed in M10 cells. This result suggests that the
suppression of ATP production by the expression of antisense
ATPase 6 thus appears to exert its e¡ect upstream of the
disruption of v8m.
3.4. Suppression of ATP production in transfectants with the
antisense ATPase 6 gene
To analyze the production of the ATP levels in the thymo-
cyte cell lines transfected with control or antisense ATPase 6
gene vectors, the luciferin-luciferase method was used. Under
regular culture conditions, maintained with 0.35% glucose-
containing RPMI 1640, the intracellular ATP levels were
more or less reduced in all the tested cell lines (Fig. 4a).
However, by incubating the cells in a glucose-free medium
with 10 WM oligomycin (an inhibitor of mitochondrial FoF1
ATPase), the kinetics in the reduction of intracellular ATP
levels were not substantially changed between M10 and
MMK12 cells (Fig. 4b). Furthermore, the addition of glucose
or the omission of oligomycin also helped to maintain the
level of ATP.
4. Discussion
In this report, we developed a functional cloning method to
isolate the genes involved in the apoptosis of thymocytes in-
duced by GCs. The cDNA library was prepared from the
Dex-resistant thymic cell line, 7-15, and we expected the iso-
lated genes to work as either antisense RNA, a dominant
negative mutant or to show an overexpression of anti-apopto-
tic activity. We here described one of the genes isolated which
was found to be identical to the antisense DNA of mitochon-
drial ATPase 6 gene which encodes a subunit of the FoF1
ATPase. Similar cloning methods have been introduced to
identify apoptosis-linked genes. Kimchi et al. isolated a series
of genes called DAP responsible for interferon-Q-induced cell
death by transfection with antisense cDNA expression libra-
ries [14]. Furthermore, by means of a functional selection
strategy, the ‘Requiem’ gene was identi¢ed to be essential
for apoptosis in the myeloid cell^interleukin 3 deprivation
system [15], and ALG-2 and ALG-3 for apoptosis in the T
cell hybridoma^TCR stimulus system [16]. It is interesting to
note that all of the genes so far isolated with these methods
are considered to work as antisense RNA.
As the isolated gene was a mitochondrial gene, the argu-
ment remains as to whether or not antisense RNA could cross
the mitochondrial membrane. However, tRNA in the cyto-
plasm has been reported to be able to cross the mitochondrial
membrane using speci¢c receptors which can recognize specif-
ic nucleotide sequences and integrate tRNA into the mito-
chondria [22]. Furthermore, Shirafuji et al. demonstrated
that antisense RNA for cytochrome c oxidase could cross
the mitochondrial membrane to exert its inhibitory e¡ect
[23]. We also demonstrated that ATP production was sup-
pressed to some extent in transfectants with the antisense
ATPase 6 gene.
The altered function of mitochondria has been recognized
for many years as an important contributor to ischemic and
necrotic death. Recently, however, evidence has accumulated
suggesting these organelles to play a critical role in apoptosis
[24]. One of the functions of the mitochondria is assumed to
be the production of ATP via the FoF1 ATPase proton pump
[25]. By employing oligomycin, a speci¢c inhibitor of the pro-
ton pump by binding to the Fo portion, it was demonstrated
that a depletion of the intracellular ATP completely blocked
apoptosis [26]. Furthermore, Matsuyama et al. screened for
yeast mutants that do not exhibit pGal-Bax-induced death on
a galactose-containing medium [27]. The authors isolated one
Fig. 4. Intracellular ATP level of thymocyte cell lines expressing
antisense transcripts to ATPase 6. a: Determination of intracellular
ATP. Intracellular ATP levels of thymocyte cell lines expressing
antisense transcripts to ATPase 6 were determined by the luciferin-
luciferase method after the cells were incubated without oligomycin
in 0.35% glucose-containing RPMI. The ATP level of control cells
(Mock; M10) cultured under normal conditions was regarded as
100%. b: Depletion of intracellular ATP level of M10 and MMK12
cells was determined by the luciferin-luciferase method after the cells
were incubated for the indicated periods with 10 WM oligomycin in
glucose-free RPMI (R), without oligomycin in glucose-free RPMI
(b) and without oligomycin in 0.35% glucose-containing RPMI (F).
The ATP level of the cells cultured under normal conditions was re-
garded as 100%.
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recessive Bax-resistant yeast mutant, and the isolated gene
ATP 4 was found to encode a subunit of the Fo portion in
the yeast FoF1 ATPase. Interestingly, ATPase 6 is also a sub-
unit of the Fo portion in the mammalian FoF1 ATPase proton
pump. In our experimental series, it is noteworthy that the
ATPase 6 antisense gene was repeatedly isolated (unpublished
observation), but the antisense genes against other subunits of
FoF1 ATPase have not been identi¢ed so far. The FoF1 ATP-
ase consists of Fo and F1 portions and the crystal structure of
the water-soluble F1 portion has been solved. However, a
transmembrane Fo portion is more complicated and little
structural information exists. Therefore, most of the informa-
tion regarding the Fo portion has been obtained based on an
analysis of the FoF1 ATPase derived from Escherichia coli.
The ATPase 6 is assumed to be equivalent to subunit a of
the bacterial Fo portion, and Fo consists of three subunits
a1b2c12. According to Rastogi and Girvin [28], subunit a plays
a critical role to lead rotation of the c12 oligomer. This rota-
tion in turn causes a rotation of the O and Q units of the F1
portion. Since ATPase 6 works as a single molecule as com-
pared to other subunits, it might thus be more easily a¡ected
by antisense gene expression.
Regarding apoptosis in thymocytes, there are at least two
principal signaling pathways. Fas antigen (CD95)-mediated
stimulation activates caspase 8 by rapid formation of the
death-induced signalling complex, followed by the activation
of caspase 3. The activation of this pathway is not blocked by
Bcl-2 [10]. In contrast, apoptosis by various stimuli including
GCs, Q-irradiation and anti-CD3 antibody is initiated at the
mitochondrion. Cytochrome c is released from the mitochon-
dria into the cytosol, and together with ATP it binds to Apaf-
1 [29,30]. This event unmasks the caspase recruitment domain
motif in Apaf-1 and allows the binding of procaspase 9. This
pathway is inhibited by Bcl-2 [31]. Following the activation of
the initiator caspase 8 or caspase 9, the two pathways con-
verge on the activation of caspase 3, which ¢nally brings cell
death. However, in caspase 3 knockout mice, thymocytes re-
main sensitive to Dex, and the death pathway by Dex may use
caspase 6, 7 or some other molecules instead of caspase 3 [10].
In these pathways, it is reasonable to assume that an over-
expression of antisense transcription of ATPase 6 reduces
ATP production, which in turn prevents the complex forma-
tion of Apaf-1 and cytochrome c. This prevention delays the
activation of caspase 9, and consequently various changes
characteristic of apoptosis are thus blocked as demonstrated
herein. However, ATP is also assumed to be involved in the
step(s) downstream of caspase 3 [32]. Furthermore, Chvatch-
ko et al. reported that P2U1 molecules, a non-selective cation
channel activated by ATP, are upregulated in thymocytes dur-
ing Dex-induced apoptosis and that antagonists to these re-
ceptors protect thymocytes from cell death [33]. In addition,
Stefanelli et al. [26] demonstrated that ATP depletion (in the
presence of oligomycin) inhibits GC-induced thymocyte apo-
ptosis, and they presented evidence that the inhibition of ap-
optosis may thus be due to a reduction in the binding of GC
receptor to the thymocyte nuclei. It is, therefore, possible that
these functions of ATP may also contribute to the e¡ects
observed in this experiment. We hope that other genes obtain-
able from this series of experiments will clarify more precisely
the mechanism of apoptosis induced by GCs and the role of
GCs in the maturation and di¡erentiation of thymocytes.
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